| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $69.3M | $73.2M | $109.7M |
| YoY Revenue Growth % | -5.3% | -33.2% | — |
| Gross Profit | $38.3M | $35.2M | — |
| Gross Margin % | 55.2% | 48.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$20.5M | -$10.8M | $5.1M |
| Operating Margin % | -29.6% | -14.8% | 4.7% |
| Net Income (GAAP) | -$14.0M | -$2.7M | -$3.0M |
| EBITDA (Normalized) | -$19.6M | -$10.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$8.7M | -$8.7M | $12.0M |
| Capital Expenditures (CapEx) | $1.2M | $369.1K | — |
| Free Cash Flow (FCF) | -$9.9M | -$9.1M | $12.0M |
| FCF Margin % | -14.3% | -12.4% | 10.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $6.1M | $5.6M | — |
| Total Debt (Short + Long Term) | $55.6K | $496.6K | — |
| Total Stockholders' Equity | $5.3M | -$88.9M | — |